Program Project Scores Have Compressed Review Shuld Return To Rank Order; Broder
In Brief: Former ICCCR Staff Form International Marketing Firm; M.D. Andersons Names New Professorship
P01 Reviewers Asked To Look Closely At Number Of Projects
Three-Quarters of P01 $$ Goes To Translational Grants, NCI Finds
Slow Accruing Trials Should Be Removed From High Priority Program, Broder Says
Score Distribution, Other Charts, On P01s
In Congress; Senate Ok’s $185 Mil. Addition For Breast Cancer
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Anthony Letai pledges to ensure stability for extramural and intramural cancer science
- Vinay Prasad to CBER employees: “It is not wise for FDA to further pollute the scientific literature with papers we cannot defend”









